The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
for the sake of elaboration LP little a is an apob containing of a protein that is different than an LDL it's often thought to be a mop or a sponge for oxidized fosol lipids and if you correct LDL levels for the amount of LP a in the LDL you see a marked decline in the correlation the association between LDL and cardiovascular disease
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.